Physician profile
Melanie Mcclain
NPI 1023374741
$1,502.84
in general payments reported to CMS, 2019-2025
17 companies · $280 in 2025
The $280 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $184 · 2021: $123 · 2022: $329 · 2023: $232 · 2024: $158 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $225.69 | 2022-2023 | Azstarys |
| Tris Pharma INC | $210.61 | 2019-2025 | Dyanavel Xr |
| Sanofi-Aventis U.S. LLC | $142.49 | 2024-2025 | |
| Kaleo, INC. | $123.45 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $123.29 | 2021-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Collegium Pharmaceutical, INC. | $110.94 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $107.80 | 2022-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $80.86 | 2021-2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $78.55 | 2021-2022 | |
| Pfizer INC. | $64.19 | 2020-2025 | |
| Seqirus USA INC | $56.52 | 2025 | Flucelvax |
| Neos Therapeutics, LP | $53.55 | 2019-2020 | |
| Genentech USA, INC. | $42.57 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $28.74 | 2023 | Flumist Quadrivalent |
| Biomarin Pharmaceutical INC. | $19.99 | 2024 | Voxzogo 1.2mg |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $17.88 | 2022 | |
| Shire North American Group INC | $15.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.